Tenaya Therapeutics, Inc. (TNYA) Operating income 2020–2025
Tenaya Therapeutics, Inc. (TNYA) annual operating income history from SEC filings — each fiscal year as reported.
-$93.3MFY2025 · since FY2020: -$38.9M → -$93.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.3M | +19.5% |
| FY2024 | -$115.9M | +11.6% |
| FY2023 | -$131.2M | -4.4% |
| FY2022 | -$125.6M | -72.5% |
| FY2021 | -$72.8M | -87.1% |
| FY2020 | -$38.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TNYA financial trends
TNYA RevenueTNYA Net incomeTNYA Net marginTNYA Gross profitTNYA Gross marginTNYA Operating marginTNYA Operating cash flowTNYA Free cash flowTNYA Capital expendituresTNYA Return on equityTNYA Stock buybacksTNYA Dividends paidTNYA Total assetsTNYA Total liabilitiesTNYA Shareholders’ equityTNYA overview →